You are here: Home » Companies » News
Business Standard

AstraZeneca Pharma inks distribution pact with Abbott for diabetes drug

AstraZeneca Pharma did not share financial details of the agreement

Press Trust of India  |  New Delhi 

medicine, drug, antibiotic, doctor, pharmaceuticals
Representative image

Drug firm Pharma Friday said it has entered into a distribution agreement with Healthcare for distribution of medicine in

Dapagliflozin, an innovative Type 2 medicine, is Pharma's leading medicine.

"Under the agreement, will promote and distribute under the brand name GLEDEPA. will also gain the rights to promote and distribute the combination of with metformin under the brand name GLEDEPA MET," Pharma said in a regulatory filing.

AstraZeneca Pharma, which did not share financial details of the agreement, said it will continue to promote and distribute dapagliflozin under the brand name Forxiga and combination of dapagliflozin with metformin under the brand name Xigduo.

Shares of were trading 0.54 per cent higher at Rs 1,341.35 apiece on BSE.

First Published: Fri, December 07 2018. 10:50 IST